Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effects of Sicilian red oranges on endothelial function and plasma antioxidant activity in adult subjects with increased cardiovascular risk
ISRCTN ISRCTN39987296
ClinicalTrials.gov identifier
Public title Effects of Sicilian red oranges on endothelial function and plasma antioxidant activity in adult subjects with increased cardiovascular risk
Scientific title Effects of Sicilian red oranges on endothelial function and plasma antioxidant activity in adult subjects with increased cardiovascular risk: a randomised placebo-controlled trial
Acronym N/A
Serial number at source 1/2010
Study hypothesis Red oranges contain antioxidants that may improve endothelial function and plasma antioxidant capacity.
Lay summary
Ethics approval Local Ethical Committee of the University Hospital of Palermo (I) approved on the 3rd February 2010 (ref: 02/2010)
Study design Randomised 2 x 2 crossed placebo-controlled single blinded trial
Countries of recruitment Italy
Disease/condition/study domain Cardiovascular and metabolic diseases
Participants - inclusion criteria 1. Male and female subjects
2. Range of age 18 - 70 years
3. Body mass index (BMI) greater than 28 kg/m^2
4. Presence of at least two of the diagnostic criteria of the Metabolic Syndrome:
4.1. Waist circumference greater than 80 cm for women and 94 cm for men
4.2. Triglycerides greater than 150 mg/dl or use of lowering blood lipid drugs
4.3. High density lipoproteins (HDL)-cholesterol less than 50 mg/dl for women or 40 mg/dl for men
4.4. Blood pressure greater than 130 mmHg for systolic or greater than 85 mmHg for diastolic blood pressure
4.5. Fasting plasma glucose greater than 100 mg/dl
Participants - exclusion criteria 1. Type 1 or 2 diabetes
2. Gastro-intestinal, connective diseases
3. Chronic pancreatitis, liver cirrhosis, kidney stones, renal failure
4. Use of acetyl-salicylic acid (ASA), other antiplatelet drugs, statins, oral hypoglycemic drugs, nitrates, non-steroidal anti-inflammatory drugs (NSAIDS), corticosteroids, drugs interfering with coagulation, supplements with vitamins and anti-oxidants
5. Pregnancy or lactation in the last six months
6. Regular sport activity
7. Denial of informed consent
Anticipated start date 01/03/2010
Anticipated end date 31/05/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 14 - 20 subjects + 10 controls
Interventions Participants with increased cardiovascular risk will receive on two periods of 7 +/- 1 days (period 1 and 2) each with 3 days intervals, with a random order respectively 500 ml/day (250 ml twice daily [bid]) of red orange juice and 500 ml of placebo made up of orange aroma and colorant, water, 11 g of saccarose, 1 g of citric acid.
Primary outcome measure(s) Endothelial function, measured as "flow mediated dilation", blood total oxidant and anti-oxidant capacity before period 1 and at the end of period 1 and 2.
Secondary outcome measure(s) 1. Glycaemic profiles and variability, before period 1 and at the end of period 1 and 2
2. Different measures of leukocytes activation and of nitric oxide production, before period 1 and at the end of period 1 and 2
Sources of funding 1. Ministry of Education and Research (Ministero dell'Università e della Ricerca - MURST) (Italy)
2. Agrumaria Corleone s.p.a. Palermo (Italy) - provided red orange juice and placebo

Added 23/02/2010:
3. Onlus: Nutrition and Health (Associazione Onlus: Nutrizione e Salute) (Italy)
Trial website
Publications
Contact name Prof  Silvio  Buscemi
  Address Dipartimento di Medicina Interna, Malattie Cardiovascolari e Nefrourologiche
Via del Vespro, 129
  City/town Palermo
  Zip/Postcode 90127
  Country Italy
  Tel +39 091 655 4580
  Fax +39 091 655 2144
  Email silbus@tin.it
Sponsor University of Palermo (Italy)
  Address Department of Internal Medicine, Cardiovascular and Kidney Diseases
Via del Vespro, 129
  City/town Palermo
  Zip/Postcode 90127
  Country Italy
  Email nutrilab.unipa@gmail.com
  Sponsor website: http://portale.unipa.it/
Date applied 07/02/2010
Last edited 23/02/2010
Date ISRCTN assigned 18/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central